Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Global BioChips and BioMEMS Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by BioChips and BioMEMS Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global BioChips and BioMEMS Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 DNA Chips
    • 1.4.3 Lab-on-a-chip
    • 1.4.4 Biosensors
    • 1.4.5 Drug Delivery Systems
    • 1.4.6 Microfluidic Devices
    • 1.4.7 Biomems Implants
    • 1.4.8 Silicon Structures
    • 1.4.9 Microactuators
  • 1.5 Market by Application
    • 1.5.1 Global BioChips and BioMEMS Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Labrary
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): BioChips and BioMEMS Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global BioChips and BioMEMS Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global BioChips and BioMEMS Growth Trends by Regions
    • 2.2.1 BioChips and BioMEMS Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 BioChips and BioMEMS Historic Market Share by Regions (2015-2020)
    • 2.2.3 BioChips and BioMEMS Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 BioChips and BioMEMS Market Growth Strategy
    • 2.3.6 Primary Interviews with Key BioChips and BioMEMS Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top BioChips and BioMEMS Players by Market Size
    • 3.1.1 Global Top BioChips and BioMEMS Players by Revenue (2015-2020)
    • 3.1.2 Global BioChips and BioMEMS Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global BioChips and BioMEMS Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global BioChips and BioMEMS Market Concentration Ratio
    • 3.2.1 Global BioChips and BioMEMS Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by BioChips and BioMEMS Revenue in 2019
  • 3.3 BioChips and BioMEMS Key Players Head office and Area Served
  • 3.4 Key Players BioChips and BioMEMS Product Solution and Service
  • 3.5 Date of Enter into BioChips and BioMEMS Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global BioChips and BioMEMS Historic Market Size by Type (2015-2020)
  • 4.2 Global BioChips and BioMEMS Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global BioChips and BioMEMS Market Size by Application (2015-2020)
  • 5.2 Global BioChips and BioMEMS Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America BioChips and BioMEMS Market Size (2015-2020)
  • 6.2 BioChips and BioMEMS Key Players in North America (2019-2020)
  • 6.3 North America BioChips and BioMEMS Market Size by Type (2015-2020)
  • 6.4 North America BioChips and BioMEMS Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe BioChips and BioMEMS Market Size (2015-2020)
  • 7.2 BioChips and BioMEMS Key Players in Europe (2019-2020)
  • 7.3 Europe BioChips and BioMEMS Market Size by Type (2015-2020)
  • 7.4 Europe BioChips and BioMEMS Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China BioChips and BioMEMS Market Size (2015-2020)
  • 8.2 BioChips and BioMEMS Key Players in China (2019-2020)
  • 8.3 China BioChips and BioMEMS Market Size by Type (2015-2020)
  • 8.4 China BioChips and BioMEMS Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan BioChips and BioMEMS Market Size (2015-2020)
  • 9.2 BioChips and BioMEMS Key Players in Japan (2019-2020)
  • 9.3 Japan BioChips and BioMEMS Market Size by Type (2015-2020)
  • 9.4 Japan BioChips and BioMEMS Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia BioChips and BioMEMS Market Size (2015-2020)
  • 10.2 BioChips and BioMEMS Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia BioChips and BioMEMS Market Size by Type (2015-2020)
  • 10.4 Southeast Asia BioChips and BioMEMS Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India BioChips and BioMEMS Market Size (2015-2020)
  • 11.2 BioChips and BioMEMS Key Players in India (2019-2020)
  • 11.3 India BioChips and BioMEMS Market Size by Type (2015-2020)
  • 11.4 India BioChips and BioMEMS Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America BioChips and BioMEMS Market Size (2015-2020)
  • 12.2 BioChips and BioMEMS Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America BioChips and BioMEMS Market Size by Type (2015-2020)
  • 12.4 Central & South America BioChips and BioMEMS Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 13.1.3 Abbott Laboratories BioChips and BioMEMS Introduction
    • 13.1.4 Abbott Laboratories Revenue in BioChips and BioMEMS Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development and Reaction to COVID-19
  • 13.2 Boston Scientific
    • 13.2.1 Boston Scientific Company Details
    • 13.2.2 Boston Scientific Business Overview and Its Total Revenue
    • 13.2.3 Boston Scientific BioChips and BioMEMS Introduction
    • 13.2.4 Boston Scientific Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.2.5 Boston Scientific Recent Development and Reaction to COVID-19
  • 13.3 Perkin Elmer
    • 13.3.1 Perkin Elmer Company Details
    • 13.3.2 Perkin Elmer Business Overview and Its Total Revenue
    • 13.3.3 Perkin Elmer BioChips and BioMEMS Introduction
    • 13.3.4 Perkin Elmer Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.3.5 Perkin Elmer Recent Development and Reaction to COVID-19
  • 13.4 Medtronic
    • 13.4.1 Medtronic Company Details
    • 13.4.2 Medtronic Business Overview and Its Total Revenue
    • 13.4.3 Medtronic BioChips and BioMEMS Introduction
    • 13.4.4 Medtronic Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.4.5 Medtronic Recent Development and Reaction to COVID-19
  • 13.5 Baxter International
    • 13.5.1 Baxter International Company Details
    • 13.5.2 Baxter International Business Overview and Its Total Revenue
    • 13.5.3 Baxter International BioChips and BioMEMS Introduction
    • 13.5.4 Baxter International Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.5.5 Baxter International Recent Development and Reaction to COVID-19
  • 13.6 Teledyne Dalsa
    • 13.6.1 Teledyne Dalsa Company Details
    • 13.6.2 Teledyne Dalsa Business Overview and Its Total Revenue
    • 13.6.3 Teledyne Dalsa BioChips and BioMEMS Introduction
    • 13.6.4 Teledyne Dalsa Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.6.5 Teledyne Dalsa Recent Development and Reaction to COVID-19
  • 13.7 Cepheid
    • 13.7.1 Cepheid Company Details
    • 13.7.2 Cepheid Business Overview and Its Total Revenue
    • 13.7.3 Cepheid BioChips and BioMEMS Introduction
    • 13.7.4 Cepheid Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.7.5 Cepheid Recent Development and Reaction to COVID-19
  • 13.8 Bluechiip
    • 13.8.1 Bluechiip Company Details
    • 13.8.2 Bluechiip Business Overview and Its Total Revenue
    • 13.8.3 Bluechiip BioChips and BioMEMS Introduction
    • 13.8.4 Bluechiip Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.8.5 Bluechiip Recent Development and Reaction to COVID-19
  • 13.9 Lepu Medical Technology
    • 13.9.1 Lepu Medical Technology Company Details
    • 13.9.2 Lepu Medical Technology Business Overview and Its Total Revenue
    • 13.9.3 Lepu Medical Technology BioChips and BioMEMS Introduction
    • 13.9.4 Lepu Medical Technology Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.9.5 Lepu Medical Technology Recent Development and Reaction to COVID-19
  • 13.10 Emulate
    • 13.10.1 Emulate Company Details
    • 13.10.2 Emulate Business Overview and Its Total Revenue
    • 13.10.3 Emulate BioChips and BioMEMS Introduction
    • 13.10.4 Emulate Revenue in BioChips and BioMEMS Business (2015-2020)
    • 13.10.5 Emulate Recent Development and Reaction to COVID-19
  • 13.11 TissUse
    • 10.11.1 TissUse Company Details
    • 10.11.2 TissUse Business Overview and Its Total Revenue
    • 10.11.3 TissUse BioChips and BioMEMS Introduction
    • 10.11.4 TissUse Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.11.5 TissUse Recent Development and Reaction to COVID-19
  • 13.12 Hesperos
    • 10.12.1 Hesperos Company Details
    • 10.12.2 Hesperos Business Overview and Its Total Revenue
    • 10.12.3 Hesperos BioChips and BioMEMS Introduction
    • 10.12.4 Hesperos Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.12.5 Hesperos Recent Development and Reaction to COVID-19
  • 13.13 CN Bio Innovations
    • 10.13.1 CN Bio Innovations Company Details
    • 10.13.2 CN Bio Innovations Business Overview and Its Total Revenue
    • 10.13.3 CN Bio Innovations BioChips and BioMEMS Introduction
    • 10.13.4 CN Bio Innovations Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.13.5 CN Bio Innovations Recent Development and Reaction to COVID-19
  • 13.14 Tara Biosystems
    • 10.14.1 Tara Biosystems Company Details
    • 10.14.2 Tara Biosystems Business Overview and Its Total Revenue
    • 10.14.3 Tara Biosystems BioChips and BioMEMS Introduction
    • 10.14.4 Tara Biosystems Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.14.5 Tara Biosystems Recent Development and Reaction to COVID-19
  • 13.15 Draper Laboratory
    • 10.15.1 Draper Laboratory Company Details
    • 10.15.2 Draper Laboratory Business Overview and Its Total Revenue
    • 10.15.3 Draper Laboratory BioChips and BioMEMS Introduction
    • 10.15.4 Draper Laboratory Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.15.5 Draper Laboratory Recent Development and Reaction to COVID-19
  • 13.16 Mimetas
    • 10.16.1 Mimetas Company Details
    • 10.16.2 Mimetas Business Overview and Its Total Revenue
    • 10.16.3 Mimetas BioChips and BioMEMS Introduction
    • 10.16.4 Mimetas Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.16.5 Mimetas Recent Development and Reaction to COVID-19
  • 13.17 Nortis
    • 10.17.1 Nortis Company Details
    • 10.17.2 Nortis Business Overview and Its Total Revenue
    • 10.17.3 Nortis BioChips and BioMEMS Introduction
    • 10.17.4 Nortis Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.17.5 Nortis Recent Development and Reaction to COVID-19
  • 13.18 Micronit Microtechnologies B.V.
    • 10.18.1 Micronit Microtechnologies B.V. Company Details
    • 10.18.2 Micronit Microtechnologies B.V. Business Overview and Its Total Revenue
    • 10.18.3 Micronit Microtechnologies B.V. BioChips and BioMEMS Introduction
    • 10.18.4 Micronit Microtechnologies B.V. Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.18.5 Micronit Microtechnologies B.V. Recent Development and Reaction to COVID-19
  • 13.19 Kirkstall
    • 10.19.1 Kirkstall Company Details
    • 10.19.2 Kirkstall Business Overview and Its Total Revenue
    • 10.19.3 Kirkstall BioChips and BioMEMS Introduction
    • 10.19.4 Kirkstall Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.19.5 Kirkstall Recent Development and Reaction to COVID-19
  • 13.20 Cherry Biotech SAS
    • 10.20.1 Cherry Biotech SAS Company Details
    • 10.20.2 Cherry Biotech SAS Business Overview and Its Total Revenue
    • 10.20.3 Cherry Biotech SAS BioChips and BioMEMS Introduction
    • 10.20.4 Cherry Biotech SAS Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.20.5 Cherry Biotech SAS Recent Development and Reaction to COVID-19
  • 13.21 Else Kooi Laboratory
    • 10.21.1 Else Kooi Laboratory Company Details
    • 10.21.2 Else Kooi Laboratory Business Overview and Its Total Revenue
    • 10.21.3 Else Kooi Laboratory BioChips and BioMEMS Introduction
    • 10.21.4 Else Kooi Laboratory Revenue in BioChips and BioMEMS Business (2015-2020)
    • 10.21.5 Else Kooi Laboratory Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    BioChips and BioMEMS market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global BioChips and BioMEMS market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the BioChips and BioMEMS market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the BioChips and BioMEMS industry.

    The key players covered in this study
    Abbott Laboratories
    Boston Scientific
    Perkin Elmer
    Medtronic
    Baxter International
    Teledyne Dalsa
    Cepheid
    Bluechiip
    Lepu Medical Technology
    Emulate
    TissUse
    Hesperos
    CN Bio Innovations
    Tara Biosystems
    Draper Laboratory
    Mimetas
    Nortis
    Micronit Microtechnologies B.V.
    Kirkstall
    Cherry Biotech SAS
    Else Kooi Laboratory

    Market segment by Type, the product can be split into
    DNA Chips
    Lab-on-a-chip
    Biosensors
    Drug Delivery Systems
    Microfluidic Devices
    Biomems Implants
    Silicon Structures
    Microactuators
    Market segment by Application, split into
    Hospital
    Labrary
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global BioChips and BioMEMS status, future forecast, growth opportunity, key market and key players.
    To present the BioChips and BioMEMS development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of BioChips and BioMEMS are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now